3YK-21485-46708
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 968 / HI
- Registered
- 2021-06-13
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-10
Dose 1 — Pfizer-BioNTech
-
2021-06-13
Registered in v-safe
-
2021-06-13
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-06-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-06-17
- 2021-06-24
- 2021-07-01
-
2021-07-02
Dose 2 — Pfizer-BioNTech
- 2021-07-16
- 2021-07-24
- 2021-07-30
- 2021-08-06
-
2021-08-13
Survey response — day 42, dose 2MedDRA: Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: NauseousMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-01
-
2021-12-31
Survey response — 6 months, dose 2MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-05
- 2022-01-12
-
2022-01-14
Dose 3 — Pfizer-BioNTech
- 2022-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-10 | Pfizer-BioNTech | |
| 2 | 2021-07-02 | Pfizer-BioNTech | No |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-31 | Unsuccessful |
Free text
Release 9 — day 42, dose 2
Symptoms: Nauseous
Release 10 — 6 months, dose 2
Symptoms: Fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | ✓ | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release